Notably, melatonin analogs contribute to the restoration of mitophagy and amelioration of behavioral abnormalities associated with cognitive deficits through the activation of the AMPK/PINK1 signaling pathway, which offers a new potential strategy for the treatment of depression [93]. This evidence concerns the gene PINK1 and major depressive disorder.